These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22113988)

  • 1. Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn's disease and the effect of therapy.
    Dörffel Y; Swidsinski A; Loening-Baucke V; Wiedenmann B; Pavel M
    Inflamm Bowel Dis; 2012 Sep; 18(9):1663-71. PubMed ID: 22113988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional biostructure of colonic microbiota (central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii].
    Swidsinski A; Loening-Baucke V; Kirsch S; Doerffel Y
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S79-92. PubMed ID: 20889010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea.
    Swidsinski A; Loening-Baucke V; Verstraelen H; Osowska S; Doerffel Y
    Gastroenterology; 2008 Aug; 135(2):568-79. PubMed ID: 18570896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.
    Swidsinski A; Loening-Baucke V; Vaneechoutte M; Doerffel Y
    Inflamm Bowel Dis; 2008 Feb; 14(2):147-61. PubMed ID: 18050295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota.
    Benjamin JL; Hedin CR; Koutsoumpas A; Ng SC; McCarthy NE; Prescott NJ; Pessoa-Lopes P; Mathew CG; Sanderson J; Hart AL; Kamm MA; Knight SC; Forbes A; Stagg AJ; Lindsay JO; Whelan K
    Inflamm Bowel Dis; 2012 Jun; 18(6):1092-100. PubMed ID: 22102318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
    Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system.
    Maccaferri S; Vitali B; Klinder A; Kolida S; Ndagijimana M; Laghi L; Calanni F; Brigidi P; Gibson GR; Costabile A
    J Antimicrob Chemother; 2010 Dec; 65(12):2556-65. PubMed ID: 20852272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease.
    Tronstad RR; Kummen M; Holm K; von Volkmann HL; Anmarkrud JA; Høivik ML; Moum B; Gilja OH; Hausken T; Baines J; Karlsen TH; Fiskerstrand T; Hov JR
    Inflamm Bowel Dis; 2017 Oct; 23(10):1752-1761. PubMed ID: 28902124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease.
    Ng SC; Benjamin JL; McCarthy NE; Hedin CR; Koutsoumpas A; Plamondon S; Price CL; Hart AL; Kamm MA; Forbes A; Knight SC; Lindsay JO; Whelan K; Stagg AJ
    Inflamm Bowel Dis; 2011 Oct; 17(10):2027-37. PubMed ID: 21910165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low counts of Faecalibacterium prausnitzii in colitis microbiota.
    Sokol H; Seksik P; Furet JP; Firmesse O; Nion-Larmurier I; Beaugerie L; Cosnes J; Corthier G; Marteau P; Doré J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1183-9. PubMed ID: 19235886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.
    Cui B; Feng Q; Wang H; Wang M; Peng Z; Li P; Huang G; Liu Z; Wu P; Fan Z; Ji G; Wang X; Wu K; Fan D; Zhang F
    J Gastroenterol Hepatol; 2015 Jan; 30(1):51-8. PubMed ID: 25168749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease.
    Gosiewski T; Strus M; Fyderek K; Kowalska-Duplaga K; Wedrychowicz A; Jedynak-Wasowicz U; Sladek M; Pieczarkowski S; Adamski P; Heczko PB
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):20-7. PubMed ID: 21788912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition.
    Shiga H; Kajiura T; Shinozaki J; Takagi S; Kinouchi Y; Takahashi S; Negoro K; Endo K; Kakuta Y; Suzuki M; Shimosegawa T
    Dig Liver Dis; 2012 Sep; 44(9):736-42. PubMed ID: 22622202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificities of the fecal microbiota in inflammatory bowel disease.
    Sokol H; Seksik P; Rigottier-Gois L; Lay C; Lepage P; Podglajen I; Marteau P; Doré J
    Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray.
    Kang S; Denman SE; Morrison M; Yu Z; Dore J; Leclerc M; McSweeney CS
    Inflamm Bowel Dis; 2010 Dec; 16(12):2034-42. PubMed ID: 20848492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlighting new phylogenetic specificities of Crohn's disease microbiota.
    Mondot S; Kang S; Furet JP; Aguirre de Carcer D; McSweeney C; Morrison M; Marteau P; Doré J; Leclerc M
    Inflamm Bowel Dis; 2011 Jan; 17(1):185-92. PubMed ID: 20722058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
    Suskind DL; Brittnacher MJ; Wahbeh G; Shaffer ML; Hayden HS; Qin X; Singh N; Damman CJ; Hager KR; Nielson H; Miller SI
    Inflamm Bowel Dis; 2015 Mar; 21(3):556-63. PubMed ID: 25647155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives.
    Joossens M; Huys G; Cnockaert M; De Preter V; Verbeke K; Rutgeerts P; Vandamme P; Vermeire S
    Gut; 2011 May; 60(5):631-7. PubMed ID: 21209126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metagenomic Analysis of Crohn's Disease Patients Identifies Changes in the Virome and Microbiome Related to Disease Status and Therapy, and Detects Potential Interactions and Biomarkers.
    Pérez-Brocal V; García-López R; Nos P; Beltrán B; Moret I; Moya A
    Inflamm Bowel Dis; 2015 Nov; 21(11):2515-32. PubMed ID: 26313691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.